AGRN anticorps
-
- Antigène Voir toutes AGRN Anticorps
- AGRN (Agrin (AGRN))
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp AGRN est non-conjugé
-
Application
- Immunohistochemistry (IHC), ELISA
- Purification
- Affinity purification
- Immunogène
- Synthetic peptide of human AGRN
- Isotype
- IgG
- Top Product
- Discover our top product AGRN Anticorps primaire
-
-
- Indications d'application
- IHC 1:25-1:100
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.3 mg/mL
- Buffer
- PBS with 0.05 % sodium azide and 50 % glycerol, PH7.4
- Agent conservateur
- Sodium azide
- Conseil sur la manipulation
- Avoid freeze / thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Avoid freeze / thaw cycles.
-
- Antigène
- AGRN (Agrin (AGRN))
- Autre désignation
- AGRN (AGRN Produits)
- Synonymes
- anticorps AGRIN, anticorps agrn, anticorps wu:fb57e07, anticorps Agrin, anticorps nmf380, anticorps AGR, anticorps HSPG, anticorps agrin, anticorps LOC465392, anticorps agrn, anticorps AGRN, anticorps Agrn
- Sujet
- This gene encodes one of several proteins that are critical in the development of the neuromuscular junction (NMJ), as identified in mouse knock-out studies. The encoded protein contains several laminin G, Kazal type serine protease inhibitor, and epidermal growth factor domains. Additional post-translational modifications occur to add glycosaminoglycans and disulfide bonds. In one family with congenital myasthenic syndrome affecting limb-girdle muscles, a mutation in this gene was found.
- NCBI Accession
- NP_940978
- Pathways
- Glycosaminoglycan Metabolic Process, Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development
-